Yılmaz, CansuAcat, MuratÖner, Serkanİnci, HabibeAdahan, Didem2024-09-292024-09-292022https://search.trdizin.gov.tr/tr/yayin/detay/1121019https://hdl.handle.net/20.500.14619/12697Objective: The objective of this study was to evaluate the effect of comorbid bronchiectasis on quality-of-life in patients with Chronic Obstructive Pulmonary Disease (COPD). Methods: 103 patients were diagnosed with COPD were included in our study. Spirometric measurements were made. The following measurement tools were used to collect data: 6-Minute Walk Test (6MWT), Modified Medical Research Council (mMRC) dyspnea scale, COPD Assessment Test (CAT), St. George Respiratory Questionnaire (SGRQ), and Short Form 36 (SF-36) quality-of-life questionnaire. Furthermore, all the patients’ high Resolution Computed Tomography (HRCT) images for the last three years were included in the study. Results: 93.2% of the patients were male, with a mean age of 64.79 ± 9.35 years. It was found that SGRQ and SF-36 quality of life scores decreased to approximately half of the full score in all patients. The volume/forced vital capacity (FEV1/FVC) values in the first second of forced expiration were significantly lower in the group with bronchiectasis. A significant correlation was found to exist between the patients’ mMRC dyspnea scale and CAT scores, 6MWT distances, and all subscales of SGRQ and SF-36. In addition, a significant correlation was also found to exist between FEV1 values and all subscales of SGRQ, and between subscales of SF- 36. Conclusions: In our study, when we compared the quality-of-life scores of the patients with COPD and bronchiectasis with those with COPD alone, we found that the quality-of-life of both groups was impaired, but there was no significant difference between them.eninfo:eu-repo/semantics/openAccessArticle3652375112101914